PHARMAC to fund new diabetes medicines with amended Special Authority criteria

21 December 2020 - PHARMAC has approved funding for two new medicines with substantial health benefits for around 53,000 New Zealanders ...

Read more →

Year in review

16 December 2020 - PHARMAC claims it funded 14 new medicines, including six new cancer medicines, and widened access to ...

Read more →

Diabetes drugs delay shows problem with PHARMAC’s funding model, doctor claims

14 December 2020 - Pharmac’s decision to delay funding approval for two new diabetes drugs has highlighted the shortcomings of ...

Read more →

Proposal to widen access to febuxostat for prevention of tumour lysis syndrome

10 December 2020 - PHARMAC is seeking feedback on a proposal to widen access to febuxostat tablets. ...

Read more →

'We're feeling broken': Taranaki father of six dies after battle for cancer drug funding

10 December 2020 - A Taranaki father who fought to get vital cancer drugs funded by the Government has lost his ...

Read more →

PHARMAC diabetes drugs delay 'bewildering', 'worse than disappointing' - doctors

7 December 2020 - A decision by PHARMAC to defer the approval of two new drugs for the treatment of diabetes ...

Read more →

Jacinda Ardern defends Labour's 'perfectly reasonable' decision to veto MP led PHARMAC inquiry

7 December 2020 - Prime Minister Jacinda Ardern is defending Labour's "perfectly reasonable" decision to veto a PHARMAC inquiry led ...

Read more →

Update on funding decision for two new diabetes medicines

7 December 2020 - PHARMAC would like to thank everyone who has provided feedback to date on a proposal to ...

Read more →

Government promises independent PHARMAC review after Labour MPs veto Health Select Committee inquiry

3 December 2020 - National MPs have lashed out at Labour for voting against a politician-led inquiry into PHARMAC but ...

Read more →

PHARMAC inquiry: “nothing should be off the table”

4 December 2020 - Medicines New Zealand, the industry association representing companies involved in the research, development and manufacture of ...

Read more →

Proposal to widen access to rituximab for treatment of membranous nephropathy

4 December 2020 - PHARMAC is seeking feedback on a proposal to widen access to rituximab. ...

Read more →

Fate of 250,000 diabetics in PHARMAC’s hands

3 December 2020 - This week, a small group of bureaucrats and health professionals will meet to agree on the ...

Read more →

PHARMAC probe unlikely to examine commercial details - Little

3 December 2020 - Work has started on setting up an inquiry into PHARMAC but it's unlikely to have access to ...

Read more →

PHARMAC boss to talk with Crohn’s sufferers protesting for drug funding

2 December 2020 - The head of the government's drug-buying agency says they would like to have the budget to fund ...

Read more →

Outraged patients to present petition with over 30,000 signatures to ask for funding for desperately needed medication

2 December 2020 - Sick of waiting for years for PHARMAC to fund standard, current therapy to treat their diseases, ...

Read more →